| Market Cap | ₹636Cr |
| ROE | 18.69% |
| P/E Ratio(TTM) | 22.38 |
| EPS(TTM) | 11.62 |
| P/B Ratio | 4.60 |
| Dividend Yield | 0.00% |
| Industry P/E | 58.35 |
| Book Value | 56.52 |
| Debt to Equity | 0.48 |
| Face Value | 10 |
| Managing Director | Chandan Singh |
| Founded | 2005 |
| NSE Symbol | CHANDAN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 43.96 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 64.59 | ||
| Metropolis Healthcare | NA (0.00%) | 58.22 | ||
| Thyrocare Technologies | NA (0.00%) | 46.28 |